発作制御を超えて:小児性の手術後の精神科併発症
Licia Salimbene1, Chiara Pepi1, Mattia Mercier1
1Neurology, Epilepsy and Movement Disorders, Bambino Gesù Children's Hospital, Full Member of European Reference Network EpiCARE, IRCCS, Rome, Italy.
Epilepsy & behavior : E&B
|February 17, 2026
まとめ
小児性手術の患者は,しばしば不安,うつ,PTSDを経験する,特に女性および発作のない患者. メンタルヘルスに関する継続的なモニタリングは,長期的な成果の改善に不可欠です.
科学分野:
- 神経学 神経学とは
- 小児精神科は,小児精神科を専門とする.
- エピレプトロジーはエピレプト学です.
背景:
- の手術は多くの患者に発作を免れる可能性を秘めているが,長期的な精神疾患の結果はあまり研究されていない.
- 精神疾患はエピレプシーにおいて一般的であり,生活の質と管理に影響を及ぼします.
- この研究は,発作後の手術を受けた小児患者の不安,うつ,PTSD,および行動障害に焦点を当てています.
研究 の 目的:
- エピレプシー手術後の小児患者の精神疾患の罹患率と関連性を調査する.
- この集団における精神疾患の併発性疾患のリスク要因を特定する.
主な方法:
- エピレプシー手術を受けた小児患者104人が,アンケートとK-SADS-PLインタビューを使用して評価されました.
- 診断はDSM-5-TRの基準に基づいて行われました.
- 収集されたデータには,発症時の年齢,手術,評価,性別,および発作の状態が含まれています.
主要な成果:
- 不安 (27.4%),うつ (18.9%),PTSD (13.6%),および行動障害 (13.5%) が一般的であった.
- 精神症状は,女性の性別と発作の自由の欠如と有意に関連していました.
- 青少年 (8~16歳) の高い割合 (83.6%) が精神症状を示した.
結論:
- 小児患者のの手術は,不安,うつ,PTSD,および行動障害の高い罹患率と関連しています.
- 精神科併発症の早期発見と継続的なモニタリングは不可欠です.
- メンタルヘルスへの取り組みは,これらの患者の長期的な生活の質を改善するために不可欠です.
さらに関連する動画
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
1.7K
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
21.2K
関連する概念動画
01:24Epilepsy and Seizures: Overview
1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
01:13Seizures: Classification
1.7K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
01:30Psychosurgery
2.0K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.0K
01:30Electroconvulsive Therapy
1.4K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.4K
01:20Antiepileptic Drugs: Potassium Channel Activators
732
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
732
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
962
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
962